| 1. | GAIN strategies for establishing IVIVC for optimum formulation development |
| 2. | DISCOVER the latest technology developments to maximize efficiency |
| 3. | IMPLEMENTquality by design through the use of dissolution testing to build in quality to your process |
| 4. | DEVELOP your method development and validation procedures to evolve with the transition of drug development |
| 5. | UTILIZE the latest dissolution strategies for improved processes and increased efficiency |
Application of IVIVC and BCS for optimum formulation development
Dongzhou J. Liu, PhD, MS, MBA Assistant Director, GlaxoSmithKline
Development of a Biorelevant In Vitro Dissolution Method Using USP Apparatus IV to Predict In Vivo Release Profile and Establish IVIVC
J.B Fang, Principal Scientist, Amgen
Performance Verification Test of Dissolution Test Equipments
Erika Stippler, PhD, Director of Dosage Form Performance Laboratory U.S. PHARMACOPEIA
Dissolution 101: Dissolution Testing and Method Development
Led by: Vivian Gray, President, V.A. Gray Consulting, Inc.
Advanced Dissolution Workshop: Practical Dissolution Case Studies
Led by: Kevin C. Bynum, Fellow, Novartis Pharmaceuticals
Tarun Patel, Group Head, Novartis Pharmaceuticals
Copyright 2003-2006 IIR Holdings, Ltd. All rights Reserved